BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month Periods Ended September 30, 2024 and 2023 Net service revenue increased $31.5 million to $587.7 million compared to $556.2 million in 2023. Net income attributable to Amedisys, Inc. of $16.9 million, which is inclusive of... Read More

BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care centers recognized by Strategic Healthcare Programs (SHP) for achieving the highest overall HHCAHPS patient satisfaction or CAHPS Hospice caregiver satisfaction scores of all eligible SHP clients in 2023. This includes 14 care... Read More

NASHVILLE, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Today, Contessa Health, a subsidiary of Amedisys Inc. (Nasdaq: AMED), announced they have been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers. Under CMS’ Guiding an Improved Dementia Experience (GUIDE) Model, Contessa will be one of... Read More

BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to $591.2 million compared to $553.0 million in 2023. Net income attributable to Amedisys, Inc. of $32.3 million, which is inclusive of merger-related expenses... Read More

BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended March 31, 2024 and 2023 Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023. Prior year included $15.0 million of net service revenue from our personal care business which was divested on... Read More

BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month Periods Ended December 31, 2023 and 2022 Net service revenue increased $8.8 million to $570.8 million compared to $562.0 million in 2022. Prior year included $15.9 million of net service revenue from our personal care business which was... Read More

BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testing to its care centers nationwide. This innovative collaboration with Patient Choice Laboratories utilizes molecular testing for the swift and precise identification of pathogens in urine, respiratory and wound infections. By... Read More

BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023. Three-Month Periods Ended September 30, 2023 and 2022 Net service revenue decreased $1.8 million to $556.2 million compared to $558.0 million in 2022. Prior year included $16.6 million of net service revenue from our personal care business which... Read More

BATON ROUGE, La., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to celebrate National Quality Week October 15-21, 2023. This week-long observance serves as an opportunity for Amedisys to recognize and highlight the organization's commitment to delivering the highest standard of quality care. During National Quality Week,... Read More

BATON ROUGE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to recognize September as Suicide Prevention Awareness Month and join the efforts to raise awareness for suicide prevention and mental health. In support of this important cause, Amedisys is highlighting the 988 Suicide and Crisis Lifeline which makes it... Read More

BATON ROUGE, La., July 26, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023. Three-Month Periods Ended June 30, 2023 and 2022 Net service revenue decreased $4.9 million to $553.0 million compared to $557.9 million in 2022. Net loss attributable to Amedisys, Inc. of $80.3 million, which is inclusive of $125.5 million in costs... Read More

BATON ROUGE, La., June 26, 2023 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agreed to combine. The agreement calls for the acquisition of Amedisys’s outstanding common stock in an all-cash transaction for $101 per share. The combination of Amedisys with Optum unites two organizations dedicated to providing... Read More

Combination would accelerate seamless provision of value-based care in the home, improving patient outcomes and experiences All-cash offer at $100 per share represents a superior proposal for Amedisys shareholders, with price certainty at a 26% premium over most recent share price EDEN PRAIRIE, Minn. / Jun 05, 2023 / Business Wire / Optum, a diversified health services company, has submitted an all-cash proposal to the Board... Read More

Amedisys Board Determines Optum Proposal Could Reasonably be Expected to Result in a Superior Proposal Amedisys Engaging in Discussions with Optum BATON ROUGE, La., June 05, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (“Amedisys” or the “Company”) (NASDAQ: AMED) today announced that on May 26, 2023, the Company received an unsolicited proposal from Optum , a diversified health services company, to acquire all of the outstanding... Read More

BATON ROUGE, La. , May 3, 2023 /PRNewswire/ -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2023. Three-Month Periods Ended March 31, 2023 and 2022 Net service revenue increased $11.1 million to $556.4 million compared to $545.3 million in 2022. Net income attributable to Amedisys, Inc. of $25.2 million compared to $31.7 million in 2022. Net income attributable... Read More

BATON ROUGE, La., April 20, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, will report results for the first quarter ended March 31, 2023, after the market closes on May 3, 2023. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on May 4, 2023. To participate on the conference call, please call a few minutes... Read More

BATON ROUGE, La., March 23, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care, supports the findings from the NORC at the University of Chicago study released by the National Association for Home Care & Hospice (NAHC) and the National Hospice and Palliative Care Organization (NHPCO) today that demonstrates the value of hospice care. “This survey supports... Read More

BATON ROUGE, La., March 13, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), the leading provider of quality home health, hospice, and high-acuity care services, today announced that its Board of Directors has named Richard Ashworth as President, Chief Executive Officer, and member of the Board of Directors. Ashworth will assume the role on April 10, 2023, from Chief Executive Officer Paul Kusserow. Kusserow will... Read More

BOULDER, Colo. , March 9, 2023 /PRNewswire/ -- nVoq Incorporated , the in-home healthcare industry's leading provider of HIPAA compliant speech recognition solutions, collaborated with Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care, to present outcomes realized during a 2022 joint study of speech recognition impact on documentation quality at the PALTC23 conference in Tampa,... Read More

BATON ROUGE, La., March 09, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul Kusserow, Chairman and Chief Executive Officer and Scott Ginn, Acting Chief Operating Officer, Executive Vice President and Chief Financial Officer, will present at Oppenheimer’s 33 rd Annual Healthcare Conference on March 14 th at 10:00... Read More

NASHVILLE, Tenn., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Today, Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, announced a new agreement with BlueCross BlueShield of Tennessee to provide members in Middle Tennessee with palliative care in the comfort of their homes. Palliative care is specialized medical care for people living with complex, chronic or advanced stage illness, such... Read More

BATON ROUGE, La., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, today announces that it has signed a definitive agreement to divest its Personal Care division to HouseWorks, LLC, a leading provider of personal care services in Massachusetts, New Hampshire, Maine and Pennsylvania. HouseWorks, in partnership with eCaring, will join the Amedisys... Read More

BATON ROUGE, La., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2022. Three-Month Periods Ended December 31, 2022 and 2021 Net service revenue increased $2.7 million to $562.0 million compared to $559.3 million in 2021. Net income attributable to Amedisys, Inc. of $31.7 million compared to $34.0 million in 2021. Net... Read More

BATON ROUGE, La., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, today announced that its Board of Directors has authorized a stock repurchase program, under which the Company may repurchase up to $100 million of its outstanding common stock through December 31, 2023. Scott Ginn, Acting Chief Operating Officer and Chief... Read More

BATON ROUGE, La., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, has recognized 39 employees with the prestigious Spirit of Excellence Awards, one of the company’s highest honors. “Our employees provide the highest quality care to our patients wherever they call home. With compassion in their hearts, they uphold our... Read More

BATON ROUGE, La., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the fourth quarter and year ended December 31, 2022, after the market closes on February 15, 2023. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on February 16, 2023. To participate on... Read More

BATON ROUGE, La., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Monday, January 9 at 8:15 p.m. ET (5:15 p.m. PT). To access a live webcast of the Amedisys presentations, please log... Read More

BATON ROUGE, La., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Foundry’s Computerworld recently named Amedisys, Inc. (NASDAQ: AMED) one of the nation’s leading home health, hospice, personal and high-acuity care companies, to their 2023 listing of the Best Places to Work in IT. This award recognizes the top organizations that challenge their IT staffs while providing great benefits and compensation. Organizations will be included in... Read More